Pancreatic cancer: New hopes after first line treatment.

Aroldi, Francesca; Bertocchi, Paola; Savelli, Giordano; Rosso, Edoardo; Zaniboni, Alberto.

Afiliação

Aroldi F; Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy.
Bertocchi P; Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy.
Savelli G; Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy.
Rosso E; Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy.
Zaniboni A; Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy.

World J Gastrointest Oncol ; 8(9): 682-7, 2016 Sep 15.

Article em En | MEDLINE | ID: mdl-27672426

ABSTRACT

Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorithm.

Palavras-chave

Algorithm; Nab-paclitaxel; Nal-iri; Pancreatic cancer; Second line

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article